The Metformin Use and Gastric Cancer Risk / 대한소화기암학회지
Journal of Digestive Cancer Report
;
(2): 97-101, 2020.
Article
in English
| WPRIM
| ID: wpr-891538
ABSTRACT
Metformin is a widely used first-line anti-diabetic drug worldwide. Epidemiologic studies using the large population-based cohort database have shown the association between metformin uses and reduced risk of various type cancers including gastric cancer. In the gastric cancer prevention, metformin use was associated with the significant reduction of gastric cancer risk, especially for long-term metformin users. However, there is no well-designed randomized controlled clinical trial investigating the effect of metformin as a chemopreventive drug for gastric cancer. Therefore, further well-designed clinical trials will be needed to implement metformin for chemoprevention of gastric cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
/
Etiology study
Language:
English
Journal:
Journal of Digestive Cancer Report
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS